Fulgent Genetics (FLGT) Earnings Date, Estimates & Call Transcripts → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free FLGT Stock Alerts $22.19 +0.44 (+2.02%) (As of 05/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 2EstimatedActual EPS (Feb. 28) -$0.02 Beat By $0.61 Consensus EPS (Feb. 28) -$0.63 Get Fulgent Genetics Earnings AlertsEnter your email address below to receive the latest news and earnings results for FLGT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueFLGT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FLGT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Fulgent Genetics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.04) EPSNext Year EPS Consensus Estimate: ($1.66) EPSFLGT Earnings Date and InformationFulgent Genetics last posted its quarterly earnings results on February 28th, 2024. The reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.63) by $0.61. The company earned $70.51 million during the quarter, compared to analysts' expectations of $67.14 million. Fulgent Genetics has generated ($5.57) earnings per share over the last year (($5.57) diluted earnings per share). Earnings for Fulgent Genetics are expected to grow in the coming year, from ($2.04) to ($1.66) per share. Fulgent Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 2nd, 2024 based off prior year's report dates.Read More Fulgent Genetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/2/2024Estimated)------- 2/28/2024Q4 2023($0.63)($0.02)+$0.61$4.26$67.14 million$70.51 million11/3/2023Q3 2023($0.32)($0.39)($0.07)($0.42)$64.42 million$84.70 million 8/4/2023Q2 2023($0.59)($0.33)+$0.26($0.28)$62.68 million$67.85 million5/5/2023Q1 2023($0.68)($0.47)+$0.21($0.42)$61.95 million$66.17 million2/28/2023Q4 2022($0.78)($0.71)+$0.07($0.62)$59.44 million$67.70 million11/7/2022Q3 2022($0.02)$0.11+$0.13$0.16$103.70 million$105.66 million Get the Latest News and Ratings for FLGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022$0.59$0.59-$0.81$122.70 million$125.30 million 5/3/2022Q1 2022$4.32$4.93+$0.61$4.93$300.50 million$320.30 million 2/23/2022Q4 2021$2.66$3.34+$0.68$3.34$191.10 million$251.67 million 11/9/2021Q3 2021$1.30$3.93+$2.63$3.93$264.00 million$227.87 million8/9/2021Q2 2021$2.54$2.47($0.07)$2.35$197.34 million$153.60 million Fulgent Genetics Earnings - Frequently Asked Questions When is Fulgent Genetics's earnings date? Fulgent Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 2nd, 2024 based off last year's report dates. Learn more on FLGT's earnings history. Did Fulgent Genetics beat their earnings estimates last quarter? In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.63) by $0.61. Learn more on analysts' earnings estimate vs. FLGT's actual earnings. How much revenue does Fulgent Genetics generate each year? Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $289.21 million. How much profit does Fulgent Genetics generate each year? Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of -$167.82 million. FLGT has generated -$5.57 earnings per share over the last four quarters. What is Fulgent Genetics's EPS forecast for next year? Fulgent Genetics's earnings are expected to grow from ($2.04) per share to ($1.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Castle Biosciences Earnings Results CareDx Earnings Results Celcuity Earnings Results Viridian Therapeutics Earnings Results Sera Prognostics Earnings Results Biodesix Earnings Results Burning Rock Biotech Earnings Results Personalis Earnings Results Renalytix Earnings Results Veracyte Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:FLGT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
